The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

NCT02700464 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
680
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nucleix Ltd.